(19)
(11) EP 1 853 302 A2

(12)

(88) Date of publication A3:
02.11.2006

(43) Date of publication:
14.11.2007 Bulletin 2007/46

(21) Application number: 06735400.1

(22) Date of filing: 17.02.2006
(51) International Patent Classification (IPC): 
A61K 38/20(2006.01)
A61K 31/517(2006.01)
A61K 31/4412(2006.01)
A61K 31/502(2006.01)
A61K 31/404(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2006/005720
(87) International publication number:
WO 2006/089150 (24.08.2006 Gazette 2006/34)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 18.02.2005 US 654341 P

(71) Applicant: Novartis Vaccines and Diagnostics, Inc.
Emeryville, CA 94662-8097 (US)

(72) Inventors:
  • AUKERMAN, Sharon Lea, Chiron Corporation
    Emeryville, CA 94608 (US)
  • DENIS-MIZE, Kimberly, Chiron Corporation
    Emeryville, CA 94608 (US)
  • ELIAS, Laurence, Chiron Corporation
    Emeryville, CA 94608 (US)
  • JALLAL, Bahija, Chiron Corporation
    Emeryville, CA 94608 (US)
  • MENEZES, Daniel, Chiron Corporation
    Emeryville, CA 94608 (US)
  • WITHERELL, Gary W., Chiron Corporation
    Emeryville, CA 94608 (US)

(74) Representative: Marshall, Cameron John et al
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)

   


(54) ANTIANGIOGENIC AGENTS WITH ALDESLEUKIN